BMS lending duo win again in $63bn AbbVie deal

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Syndicated Loans
Investment Grade Loans

BMS lending duo win again in $63bn AbbVie deal

Mike Turner
June 26, 2019 01:45 PM
AbbVie
A logo sign outside of a facility occupied by AbbVie, Inc., in Cambridge, Massachusetts on Feb. 21, 2018. A federal judge has ordered AbbVie to pay $3.2 million. (Photo by Kristoffer Tripplaar/Sipa USA/TNS/Sipa USA) | TNS/SIPA USA/PA Images

The loan desks at Morgan Stanley and MUFG are big winners in AbbVie’s around $63bn purchase of Botox maker Allergan, with the banks picked to provide more than half of the purchase price in underwritten debt.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Syndicated LoansMorgan StanleyMUFGInvestment Grade Loans
MT
Mike Turner
Corporate Debt Editor
Contact
Gift this article